A detailed history of Thrivent Financial For Lutherans transactions in Innoviva, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 45,618 shares of INVA stock, worth $881,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,618
Previous 48,925 6.76%
Holding current value
$881,339
Previous $746,000 0.27%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$14.4 - $16.4 $47,620 - $54,234
-3,307 Reduced 6.76%
45,618 $748,000
Q1 2024

May 14, 2024

SELL
$14.56 - $16.78 $19,350 - $22,300
-1,329 Reduced 2.64%
48,925 $746,000
Q4 2023

Feb 14, 2024

SELL
$12.32 - $16.27 $26,500 - $34,996
-2,151 Reduced 4.1%
50,254 $806,000
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $49,381 - $55,448
-3,992 Reduced 7.08%
52,405 $681,000
Q2 2023

Aug 14, 2023

SELL
$11.39 - $13.72 $96,849 - $116,661
-8,503 Reduced 13.1%
56,397 $718,000
Q1 2023

May 17, 2023

BUY
$10.73 - $13.6 $5,128 - $6,500
478 Added 0.74%
64,900 $730,000
Q4 2022

Feb 08, 2023

SELL
$11.8 - $13.78 $5,062 - $5,911
-429 Reduced 0.66%
64,422 $854,000
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $37,407 - $49,038
3,222 Added 5.23%
64,851 $753,000
Q2 2022

Aug 16, 2022

BUY
$14.32 - $19.88 $153,438 - $213,014
10,715 Added 21.05%
61,629 $910,000
Q1 2022

May 13, 2022

BUY
$15.39 - $20.25 $246 - $324
16 Added 0.03%
50,914 $985,000
Q4 2021

Feb 16, 2022

BUY
$15.91 - $18.72 $5,441 - $6,402
342 Added 0.68%
50,898 $878,000
Q3 2021

Nov 15, 2021

SELL
$13.06 - $17.24 $11,009 - $14,533
-843 Reduced 1.64%
50,556 $845,000
Q2 2021

Aug 19, 2021

SELL
$11.45 - $13.96 $2,759 - $3,364
-241 Reduced 0.47%
51,399 $689,000
Q1 2021

May 17, 2021

SELL
$11.06 - $12.87 $4,346 - $5,057
-393 Reduced 0.76%
51,640 $617,000
Q4 2020

Feb 16, 2021

SELL
$9.33 - $12.48 $858 - $1,148
-92 Reduced 0.18%
52,033 $645,000
Q3 2020

Nov 10, 2020

SELL
$10.33 - $14.49 $39,739 - $55,743
-3,847 Reduced 6.87%
52,125 $545,000
Q2 2020

Aug 12, 2020

SELL
$11.49 - $15.26 $563 - $747
-49 Reduced 0.09%
55,972 $782,000
Q1 2020

May 15, 2020

BUY
$8.11 - $15.23 $22,675 - $42,583
2,796 Added 5.25%
56,021 $659,000
Q4 2019

Feb 13, 2020

BUY
$10.28 - $14.38 $1,161 - $1,624
113 Added 0.21%
53,225 $754,000
Q3 2019

Nov 14, 2019

SELL
$10.05 - $14.55 $412 - $596
-41 Reduced 0.08%
53,112 $560,000
Q2 2019

Aug 13, 2019

BUY
$13.1 - $14.95 $18,654 - $21,288
1,424 Added 2.75%
53,153 $774,000
Q1 2019

May 14, 2019

BUY
$13.69 - $20.06 $55,663 - $81,563
4,066 Added 8.53%
51,729 $726,000
Q4 2018

Feb 15, 2019

SELL
$13.96 - $18.26 $7,021 - $9,184
-503 Reduced 1.04%
47,663 $832,000
Q3 2018

Nov 15, 2018

BUY
$13.63 - $15.7 $11,571 - $13,329
849 Added 1.79%
48,166 $734,000
Q1 2018

May 08, 2018

BUY
$13.8 - $16.99 $13,717 - $16,888
994 Added 2.15%
47,317 $789,000
Q4 2017

Feb 14, 2018

BUY
$11.73 - $14.75 $10,709 - $13,466
913 Added 2.01%
46,323 $657,000
Q3 2017

Nov 14, 2017

BUY
$12.06 - $14.12 $547,644 - $641,189
45,410
45,410 $641,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.35B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.